Literature DB >> 7884925

Symmetric-strand packaging of recombinant parvovirus LuIII genomes that retain only the terminal regions.

J Corsini1, J O Carlson, F Maxwell, I H Maxwell.   

Abstract

LuIII is an autonomous parvovirus which encapsidates either strand of its genome with similar efficiency in NB324K cells. Two parvoviruses closely related to LuIII, minute virus of mice (MVM) and H-1 virus, encapsidate primarily the minus strand of their genome when grown in the same cell type. It has been postulated that an AT-rich region unique to LuIII is responsible for symmetric encapsidation of plus- and minus-strand genomes by LuIII. To address this hypothesis, recombinant LuIII-luciferase genomes containing or lacking the AT-rich sequence (AT) were packaged into LuIII virions. Hybridization of strand-specific probes to DNA from these virions revealed that either strand of the genome was packaged regardless of the presence of AT. In addition, encapsidation of both strands of the AT+ LuIII-luciferase genome into MVM and H-1 virions was observed, suggesting that MVM and H-1 viral proteins are not responsible for the minus-strand packaging bias of these two viruses. Alignment of the published LuIII and MVMp sequences shows that AT exists as an insertion into an element that, in MVM, binds cellular proteins. We suggest that in LuIII, AT disrupts binding of these cellular proteins, allowing encapsidation of either strand.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884925      PMCID: PMC188957     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  Replication process of the parvovirus H-1 V. Isolation and characterization of temperature-sensitive H-1 mutants.

Authors:  S L Rhode
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

3.  Assembly of adeno-associated virus.

Authors:  M W Myers; B J Carter
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

4.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

5.  Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function.

Authors:  J D Tratschin; I L Miller; B J Carter
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  The complete DNA sequence of minute virus of mice, an autonomous parvovirus.

Authors:  C R Astell; M Thomson; M Merchlinsky; D C Ward
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

7.  Autonomous parvovirus LuIII encapsidates equal amounts of plus and minus DNA strands.

Authors:  R C Bates; C E Snyder; P T Banerjee; S Mitra
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

8.  Characterization and molecular cloning of a human parvovirus genome.

Authors:  S F Cotmore; P Tattersall
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

9.  Maturation of parvovirus LuIII in a subcellular system. I. Optimal conditions for in vitro synthesis and encapsidation of viral DNA.

Authors:  D E Muller; G Siegl
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

10.  Maturation of parvovirus LuIII in a subcellular system. II. Isolation and characterization of nucleoprotein intermediates.

Authors:  D E Muller; G Siegl
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

View more
  2 in total

1.  Genome packaging sense is controlled by the efficiency of the nick site in the right-end replication origin of parvoviruses minute virus of mice and LuIII.

Authors:  Susan F Cotmore; Peter Tattersall
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 2.  Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Authors:  Julia Fakhiri; Dirk Grimm
Journal:  Mol Ther       Date:  2021-04-05       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.